000078 海王生物
已收盘 12-19 15:00:00
资讯
新帖
简况
海王生物（000078）12月13日主力资金净卖出3015.40万元
证券之星 · 12-16
海王生物（000078）12月13日主力资金净卖出3015.40万元
海王生物（000078）股东深圳海王集团股份有限公司质押1.38亿股，占总股本5.23%
证券之星 · 12-03
海王生物（000078）股东深圳海王集团股份有限公司质押1.38亿股，占总股本5.23%
海王生物：深圳泽源投资、深天润资管等多家机构于11月13日调研我司
证券之星 · 11-14
海王生物：深圳泽源投资、深天润资管等多家机构于11月13日调研我司
海王生物：山西证券投资者于11月8日调研我司
证券之星 · 11-08
海王生物：山西证券投资者于11月8日调研我司
海王生物因未及时披露公司重大事件等违规行为被证监会责令改正
证券之星 · 10-31
海王生物因未及时披露公司重大事件等违规行为被证监会责令改正
海王生物：董事局主席张思民、总裁张锋等多人因未及时披露公司重大事件等违规行为被证监会出具警示函
证券之星 · 10-31
海王生物：董事局主席张思民、总裁张锋等多人因未及时披露公司重大事件等违规行为被证监会出具警示函
海王生物遭深圳证监局责令改正 ，前三季度利润同比下跌47.77%
读创客户端 · 10-30
海王生物遭深圳证监局责令改正 ，前三季度利润同比下跌47.77%
海王生物：如有最新进展，公司将根据相关法律法规的要求及时履行信息披露义务
证券之星 · 09-10
海王生物：如有最新进展，公司将根据相关法律法规的要求及时履行信息披露义务
海王生物：截至目前，公司实际控制人为张思民先生
证券之星 · 09-02
海王生物：截至目前，公司实际控制人为张思民先生
图解海王生物中报：第二季度单季净利润同比减78.94%
证券之星 · 08-31
图解海王生物中报：第二季度单季净利润同比减78.94%
海王生物(000078.SZ)发布上半年业绩，净利润4540.98万元，下降48.21%
智通财经网 · 08-30
海王生物(000078.SZ)发布上半年业绩，净利润4540.98万元，下降48.21%
海王生物最新公告：2024年上半年净利润同比下降48.21%
证券之星 · 08-30
海王生物最新公告：2024年上半年净利润同比下降48.21%
海王生物：公司没有相关药物的研发
证券之星 · 08-16
海王生物：公司没有相关药物的研发
广东国资入主能否纾困海王生物?
媒体滚动 · 08-10
广东国资入主能否纾困海王生物?
海王生物：8月7日接受媒体采访，《中国经营报》参与
证券之星 · 08-07
海王生物：8月7日接受媒体采访，《中国经营报》参与
22亿让出控制权还背负业绩对赌，海王生物到底怎么了？
第一财经 · 08-04
22亿让出控制权还背负业绩对赌，海王生物到底怎么了？
海王生物易主！派林生物、广誉远、康恩贝，下一个国资入主的是天士力吗？
医药经济报 · 08-02
海王生物易主！派林生物、广誉远、康恩贝，下一个国资入主的是天士力吗？
海王生物最新公告：实控人拟变更为广东省人民政府
证券之星 · 07-30
海王生物最新公告：实控人拟变更为广东省人民政府
海王生物：公司实控人将变更为广东省人民政府海王生物公告，海王集团将其持有的公司31573.48万股股份协议转让给丝纺集团。
格隆汇 · 07-30
海王生物：公司实控人将变更为广东省人民政府海王生物公告，海王集团将其持有的公司31573.48万股股份协议转让给丝纺集团。
海王生物新注册《海王生物TMS云平台V1.0》项目的软件著作权
证券之星 · 07-30
海王生物新注册《海王生物TMS云平台V1.0》项目的软件著作权
加载更多
公司概况
公司名称：
深圳市海王生物工程股份有限公司
所属行业：
零售业
上市日期：
1998-12-18
主营业务：
深圳市海王生物工程股份有限公司主营业务是生物制品、生化制品、海洋药物、海洋生物制品、中成药的生产销售。主要产品是抗肿瘤、麻醉精神类药、肠外营养药、基础输液类、现代中成药、中成药、化药。
发行价格：
5.36
{"stockData":{"symbol":"000078","market":"SZ","secType":"STK","nameCN":"海王生物","latestPrice":2.81,"timestamp":1734591804000,"preClose":2.84,"halted":0,"volume":21699950,"delay":0,"floatShares":2626000000,"shares":2631000000,"eps":-0.6584,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.03,"latestTime":"12-19 15:00:00","open":2.83,"high":2.85,"low":2.77,"amount":60713600,"amplitude":0.0282,"askPrice":2.82,"askSize":4188,"bidPrice":2.81,"bidSize":2012,"shortable":0,"etf":0,"ttmEps":-0.6584,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"adjPreClose":2.84,"symbolType":"stock","openAndCloseTimeList":[[1734571800000,1734579000000],[1734584400000,1734591600000]],"highLimit":3.12,"lowLimit":2.56,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2631123257,"pbRate":2.46,"roa":"--","roe":"1.53%","epsLYR":-0.6423,"committee":0.104712,"marketValue":7393000000,"floatMarketCap":7380000000,"peRate":-4.267922,"changeRate":-0.0106,"turnoverRate":0.0083,"status":1},"requestUrl":"/m/hq/s/000078","defaultTab":"news","newsList":[{"id":"2491268501","title":"海王生物（000078）12月13日主力资金净卖出3015.40万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491268501","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491268501?lang=zh_cn&edition=full","pubTime":"2024-12-16 09:32","pubTimestamp":1734312723,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月13日收盘，海王生物报收于2.99元，下跌4.47%，换手率1.86%，成交量48.88万手，成交额1.48亿元。近5日资金流向一览见下表：海王生物融资融券信息显示，融资方面，当日融资买入1071.06万元，融资偿还1129.21万元，融资净偿还58.15万元。海王生物主营业务：涵盖医药商业流通、医药制造、医药研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121600002466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","000078","BK0168","BK0209","BK0060"],"gpt_icon":0},{"id":"2488689910","title":"海王生物（000078）股东深圳海王集团股份有限公司质押1.38亿股，占总股本5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488689910","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488689910?lang=zh_cn&edition=full","pubTime":"2024-12-03 21:37","pubTimestamp":1733233039,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物12月3日公开信息显示，股东深圳海王集团股份有限公司向中国建设银行股份有限公司深圳市分行合计质押1.38亿股，占总股本5.23%。质押详情见下表：截止本公告日，股东深圳海王集团股份有限公司已累计质押股份12.14亿股，占其持股总数的99.83%。海王生物主营业务：涵盖医药商业流通、医药制造、医药研发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120300039325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0168","BK0188","000078","BK0060","BK0209"],"gpt_icon":0},{"id":"2483042891","title":"海王生物：深圳泽源投资、深天润资管等多家机构于11月13日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2483042891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483042891?lang=zh_cn&edition=full","pubTime":"2024-11-14 11:33","pubTimestamp":1731555239,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年11月13日海王生物发布公告称深圳泽源投资、深天润资管、锦世翔投资、投资者、泽源太空融基金、华安证券、国诚投资、小忠资本、前海恒江联合、深圳征途投资、德讯证顾、红思客资产于2024年11月13日调研我司。公司将持续关注相关政策落地情况，积极做好应收账款收工作。海王生物主营业务：涵盖医药商业流通、医药制造、医药研发。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400016352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000078","BK0168","BK0209","BK0028","BK0060"],"gpt_icon":0},{"id":"2481102438","title":"海王生物：山西证券投资者于11月8日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2481102438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481102438?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:04","pubTimestamp":1731078283,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年11月8日海王生物发布公告称山西证券叶中正 魏赟于2024年11月8日调研我司。同时，利用整体海王体系资源，加大公司医药工业产品的市场份额，提高毛利率。未来，公司医疗器械业务的营收占比将进一步提升，成为公司利润增长点。海王生物主营业务：涵盖医药商业流通、医药制造、医药研发。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800044850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002500","BK0188","BK0276","000078","BK0060","BK0209","BK0168","BK0183","BK0028"],"gpt_icon":0},{"id":"2479732983","title":"海王生物因未及时披露公司重大事件等违规行为被证监会责令改正","url":"https://stock-news.laohu8.com/highlight/detail?id=2479732983","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479732983?lang=zh_cn&edition=full","pubTime":"2024-10-31 01:00","pubTimestamp":1730307649,"startTime":"0","endTime":"0","summary":"证券之星消息，10月31日海王生物公开信息显示，深圳市海王生物工程股份有限公司因未及时披露公司重大事件,信息披露违规,未依法履行其他职责被中国证券监督管理委员会深圳监管局责令改正。前述情况不符合《企业会计准则——基本准则》第十二条、第十九条的规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100002014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0209","BK0168","BK0188","BK0028","000078"],"gpt_icon":0},{"id":"2479666732","title":"海王生物：董事局主席张思民、总裁张锋等多人因未及时披露公司重大事件等违规行为被证监会出具警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2479666732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479666732?lang=zh_cn&edition=full","pubTime":"2024-10-31 01:00","pubTimestamp":1730307644,"startTime":"0","endTime":"0","summary":"证券之星消息，10月31日海王生物公开信息显示，董事局主席张思民、总裁张锋、副总裁沈大凯、副总裁王云雷因未及时披露公司重大事件,信息披露违规,未依法履行其他职责被中国证券监督管理委员会深圳监管局出具警示函。详细违规行为如下：经查,公司在公司治理、信息披露、财务会计核算等方面存在不规范情形。处罚决定如下：采取出具警示函的监管措施以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100002008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000078","BK0209","BK0168","BK0188","BK0028"],"gpt_icon":0},{"id":"2479444206","title":"海王生物遭深圳证监局责令改正 ，前三季度利润同比下跌47.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479444206","media":"读创客户端","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479444206?lang=zh_cn&edition=full","pubTime":"2024-10-30 19:24","pubTimestamp":1730287440,"startTime":"0","endTime":"0","summary":"深圳商报·读创客户端记者 舒桂林海王生物10月30日晚间发布公告称，近日收到深圳证监局下发的《责令改正措施决定书》。10月30日晚间，海王生物还发布了2024年度三季报。财报显示，公司前三季度实现利润4621万元，同比下跌幅度达47.77%。财报数据显示，2018年—2023年，海王生物已连续六年资产负债率超过80%。截至2024年上半年，公司资产负债率已上升至86.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-30/doc-incuitnt7789518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0060","BK0209","BK0188","000078","BK0168"],"gpt_icon":0},{"id":"2466434963","title":"海王生物：如有最新进展，公司将根据相关法律法规的要求及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2466434963","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466434963?lang=zh_cn&edition=full","pubTime":"2024-09-10 20:00","pubTimestamp":1725969626,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物(000078)09月10日在投资者关系平台上答复投资者关心的问题。投资者：请问公司之前公告过开始美国临床实验的虎杖苷注射液现在进展如何，怎么很久没有公告进展了，是失败了吗？海王生物董秘：您好，感谢您的关注。如有最新进展，公司将根据相关法律法规的要求及时履行信息披露义务。谢谢！以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091000033490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0209","BK0028","BK0188","BK0060","000078"],"gpt_icon":0},{"id":"2464088289","title":"海王生物：截至目前，公司实际控制人为张思民先生","url":"https://stock-news.laohu8.com/highlight/detail?id=2464088289","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464088289?lang=zh_cn&edition=full","pubTime":"2024-09-02 18:03","pubTimestamp":1725271395,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物(000078)09月02日在投资者关系平台上答复投资者关心的问题。投资者：贵公司实控人变更了没有？海王生物董秘：您好，感谢您的关注。截至目前，公司实际控制人为张思民先生。谢谢！以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090200025547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000078","BK0209","BK0168","BK0188","BK0028"],"gpt_icon":0},{"id":"2463767226","title":"图解海王生物中报：第二季度单季净利润同比减78.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463767226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463767226?lang=zh_cn&edition=full","pubTime":"2024-08-31 01:56","pubTimestamp":1725040560,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物2024年中报显示，公司主营收入166.31亿元，同比下降16.65%；归母净利润4540.98万元，同比下降48.21%；扣非净利润3890.17万元，同比下降28.11%；其中2024年第二季度，公司单季度主营收入85.44亿元，同比下降14.53%；单季度归母净利润276.84万元，同比下降78.94%；单季度扣非净利润-847.06万元，同比下降187.99%；负债率86.62%，投资收益-946.94万元，财务费用3.67亿元，毛利率10.06%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083100004432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000078"],"gpt_icon":0},{"id":"2463342717","title":"海王生物(000078.SZ)发布上半年业绩，净利润4540.98万元，下降48.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463342717","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463342717?lang=zh_cn&edition=full","pubTime":"2024-08-30 20:30","pubTimestamp":1725021032,"startTime":"0","endTime":"0","summary":"海王生物(000078.SZ)发布2024年半年度报告，该公司营业收入为166.3...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/24.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/24.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1177008.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["000078"],"gpt_icon":0},{"id":"2463735320","title":"海王生物最新公告：2024年上半年净利润同比下降48.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463735320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463735320?lang=zh_cn&edition=full","pubTime":"2024-08-30 19:19","pubTimestamp":1725016784,"startTime":"0","endTime":"0","summary":"海王生物发布2024年半年度报告摘要，报告期内，公司实现营业收入166.31亿元，同比下降16.65%；归属于上市公司股东的净利润4540.98万元，同比下降48.21%；基本每股收益0.0173元。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083000040526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000078"],"gpt_icon":0},{"id":"2459859297","title":"海王生物：公司没有相关药物的研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2459859297","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459859297?lang=zh_cn&edition=full","pubTime":"2024-08-16 19:02","pubTimestamp":1723806161,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物(000078)08月16日在投资者关系平台上答复投资者关心的问题。投资者：请问董秘：目前非洲至少有16个国家受到猴痘影响；与2023年同期相比，非洲今年报告的猴痘病例增加了160%。为此，作为有责任的国药企是否会研究解决猴痘疫苗或治疗药物？？海王生物董秘：您好，感谢您的关注。公司没有相关药物的研发。谢谢！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081600044059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000078","BK0188","BK0209","BK0028","BK0168"],"gpt_icon":0},{"id":"2458654600","title":"广东国资入主能否纾困海王生物?","url":"https://stock-news.laohu8.com/highlight/detail?id=2458654600","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458654600?lang=zh_cn&edition=full","pubTime":"2024-08-10 03:56","pubTimestamp":1723233360,"startTime":"0","endTime":"0","summary":" 时隔两年半，海王生物筹划的资产重组事项终落定。上述协议转让完成、海王集团及其一致行动人放弃表决权后，海王生物控股股东变更为丝纺集团，实际控制人变更为广东省人民政府。此次，丝纺集团及其一致行动人拿下海王生物控制权将耗资约22.55亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-08-10/doc-inciavfq0229899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0168","000078","BK0060","BK0209","BK0028","BK0188"],"gpt_icon":0},{"id":"2457819932","title":"海王生物：8月7日接受媒体采访，《中国经营报》参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2457819932","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457819932?lang=zh_cn&edition=full","pubTime":"2024-08-07 18:52","pubTimestamp":1723027936,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年8月7日海王生物发布公告称公司于2024年8月7日接受媒体采访，《中国经营报》记者 苏浩 曹学平参与。近年来，受集中带量采购、国家医保谈判降价等政策的冲击，叠加公司主要医院客户资金紧张，公司应收账款款周期拉长。海王集团股份转让及表决权放弃后，公司控股股东将变更为丝纺集团，公司实际控制人将变更为广东省人民政府。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080700038643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000078","BK0168","BK0209","BK0188","BK0060","BK0028"],"gpt_icon":0},{"id":"2456205400","title":"22亿让出控制权还背负业绩对赌，海王生物到底怎么了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2456205400","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456205400?lang=zh_cn&edition=full","pubTime":"2024-08-04 08:10","pubTimestamp":1722730200,"startTime":"0","endTime":"0","summary":"近年来海王生物的资产负债率较高，公司现金流紧张，卖身国企一方面可以通过股权换现金，另一方面也能解上市公司现金流压力的燃眉之急。 最近，张思明掌控的海王生物披露多份公告称，欲将持有的上市公司部分股权转让给广东省国资，控制权一并“相让”的同时，还背负三年业绩对赌。 连日来，海王生物股价持续震荡，截至8月2日收盘，报收2.45元，跌幅0.41%，总市值67.40亿元。完成回购注销之后，海王生物股份总数26.31亿股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-08-04/doc-inchmtfr9103150.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-08-04/doc-inchmtfr9103150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0168","BK0188","000078","BK0209","BK0060","BK0028"],"gpt_icon":0},{"id":"2456740950","title":"海王生物易主！派林生物、广誉远、康恩贝，下一个国资入主的是天士力吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2456740950","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456740950?lang=zh_cn&edition=full","pubTime":"2024-08-02 18:55","pubTimestamp":1722596146,"startTime":"0","endTime":"0","summary":"事实上，海王生物资产重组此前已有预兆。据悉，在官宣资产重组之后，海王生物积极与各战略投资者沟通，并签署了非排他性的保密协议。这一定增计划无疑将进一步强化丝纺集团及其控股股东广新集团在海王生物中的话语权。因此，海王生物的实际控制人将变更为广东省人民政府。此番交易后，胜帮英豪获取了派林生物23.01%的表决权，成为其第一大股东。广誉远的控股股东由东盛集团变更为晋创投资，实际控制人变更为山西省国资委。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408021910409f08bbb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408021910409f08bbb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0183","600535","BK0012","BK0060","600572","BK0071","BK0077","BK0028","BK0097","BK0188","BK0209","BK0239","000078","000403","BK0168","600771","BK0196"],"gpt_icon":0},{"id":"2455493941","title":"海王生物最新公告：实控人拟变更为广东省人民政府","url":"https://stock-news.laohu8.com/highlight/detail?id=2455493941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455493941?lang=zh_cn&edition=full","pubTime":"2024-07-30 20:31","pubTimestamp":1722342666,"startTime":"0","endTime":"0","summary":"海王生物公告，公司控股股东海王集团将其持有的公司11.48%股份通过协议转让的方式转让给丝纺集团；海王集团及其一致行动人放弃其所持有股份对应的表决权；丝纺集团、广新集团认购公司向特定对象发行股份。上述协议转让完成、海王集团及其一致行动人放弃表决权后，公司实际控制人将变更为广东省人民政府。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073000041243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000078","BK0188","BK0209","BK0028","BK0168"],"gpt_icon":0},{"id":"2455936642","title":"海王生物：公司实控人将变更为广东省人民政府海王生物公告，海王集团将其持有的公司31573.48万股股份协议转让给丝纺集团。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455936642","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455936642?lang=zh_cn&edition=full","pubTime":"2024-07-30 20:19","pubTimestamp":1722341983,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0168","000078","BK0060","BK0209","BK0028","BK0188"],"gpt_icon":0},{"id":"2455699972","title":"海王生物新注册《海王生物TMS云平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2455699972","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455699972?lang=zh_cn&edition=full","pubTime":"2024-07-30 01:24","pubTimestamp":1722273880,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海王生物（000078）新注册了《海王生物TMS云平台V1.0》项目的软件著作权。今年以来海王生物新注册软件著作权3个，较去年同期减少了40%。结合公司2023年年报财务数据，2023年公司在研发方面投入了4793.81万元，同比减1.02%。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073000001796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000078","BK0168","BK0209","BK0188","BK0060","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1998-12-18","address":"广东省深圳市南山区科技中三路1号海王银河科技大厦24层","stockEarnings":[{"period":"1week","weight":-0.0749},{"period":"1month","weight":0},{"period":"3month","weight":0.3148},{"period":"6month","weight":0.3028},{"period":"1year","weight":-0.0533},{"period":"ytd","weight":-0.0955}],"companyName":"深圳市海王生物工程股份有限公司","boardCode":"AI0052","perCapita":"19963股","boardName":"零售业","registeredCapital":"263112万元","compareEarnings":[{"period":"1week","weight":-0.0146},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.2362},{"period":"6month","weight":0.1281},{"period":"1year","weight":0.1534},{"period":"ytd","weight":0.1369}],"survey":" 深圳市海王生物工程股份有限公司主营业务是生物制品、生化制品、海洋药物、海洋生物制品、中成药的生产销售。主要产品是抗肿瘤、麻醉精神类药、肠外营养药、基础输液类、现代中成药、中成药、化药。","serverTime":1734591864613,"listedPrice":5.36,"stockholders":"131564人(较上一季度减少1.66%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海王生物(000078)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海王生物(000078)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海王生物,000078,海王生物股票,海王生物股票老虎,海王生物股票老虎国际,海王生物行情,海王生物股票行情,海王生物股价,海王生物股市,海王生物股票价格,海王生物股票交易,海王生物股票购买,海王生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海王生物(000078)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海王生物(000078)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}